Your browser doesn't support javascript.
loading
Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial.
Glesby, Marshall J; Albu, Jeanine; Chiu, Ya-Lin; Ham, Kirsis; Engelson, Ellen; He, Qing; Muthukrishnan, Varalakshmi; Ginsberg, Henry N; Donovan, Daniel; Ernst, Jerry; Lesser, Martin; Kotler, Donald P.
Affiliation
  • Glesby MJ; Department of Medicine, Weill Cornell Medical College, New York, New York, USA. mag2005@med.cornell.edu
PLoS One ; 8(4): e61160, 2013.
Article in En | MEDLINE | ID: mdl-23593417

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Insulin Resistance / HIV Infections / Human Growth Hormone / Thiazolidinediones / Abdominal Fat Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2013 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Insulin Resistance / HIV Infections / Human Growth Hormone / Thiazolidinediones / Abdominal Fat Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2013 Document type: Article Affiliation country: United States